| Net Cash Provided by (Used in) Operating Activities |
3.52K |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
-25.2K |
USD |
-178% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200M |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
182M |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-21.7K |
USD |
-1234% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
4.66M |
USD |
+0.26% |
Q2 2025 |
Q2 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
4.66M |
USD |
+0.26% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
17.9M |
USD |
+0.26% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Issued |
1 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
19.2M |
USD |
0% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Outstanding |
1 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |